-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - We did not identify eligible trials of
antihistaminergic drugs or alcohol. … We have added text describe how specific drugs or
formulations can be used to target specific sleep … problems (Introduction: ‘Drugs can be specifically
formulated…’). … One of the most commonly
used drugs for insomnia. No evidence. … Drugs Aging. 2014 Oct;31(10):731-6.
doi: 10.1007/s40266-014-0211-3.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - These approval
documents—which can be found at Drugs@FDA.gov—may help identify publication bias even … Ottawa: Canadian Agency for
Drugs and Technologies in Health; 2008.
46. … Ottawa: Canadian Agency for Drugs
and Technologies in Health. … an
pharmaceuticals, more non-U.S. coverage than
MEDLINE
Avenell, 2001
Minozzi, 2000
Sampson, … and pharmaceuticals Fishman, 1996
Wolfe, 2002
MANTIS
(Manual Alternative and Natural
Therapy Index
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
November 01, 2022 - Medicare beneficiaries.1 Thus, CMS makes decisions
about providing insurance coverage for use of these drugs … For
studies that involve researching
the safety and effectiveness of
new drugs and biological
products … For studies that involve researching the safety and
effectiveness of new drugs and biological products … there may not be the extensive clinical trial record that is generated during
regulatory approval of pharmaceuticals … Specification for Cancer Drugs Fund data collection arrangements.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the four topics for which (1) preliminary phase III data for drugs or … interventions in this Executive Summary and report is organized
alphabetically by device and then, pharmaceuticals … phentermine-
topiramate (Qsymia®, Vivus, Inc., Mountain View, CA) and lorcaserin (Belviq®, Arena
Pharmaceuticals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/insomnia_executive.pdf
December 01, 2015 - Prescription drugs are often used to treat insomnia. … We
found the most data on the newer FDA-approved drugs. … Results for adverse effects
varied across the different drugs and typically were not
different from … Drug trials
for certain drugs often used doses that are no longer
recommended by the FDA. … Drug Class Review:
Newer Drugs for Insomnia: Final Report Update 2 [Internet].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
January 01, 2009 - corticosteroids, immune system suppressors,
antibiotics, anti-diarrheals, anti-tumor necrosis factor (TNF) drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
January 01, 2009 - A number of drugs and dietary measures have been shown to reduce the rate of stone
recurrence.
-
effectivehealthcare-admin.ahrq.gov/health-topics/carbohydrates?page=2
January 01, 2005 - Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … drug
in some state Medicare drug plan formularies, which is the highest pricing tier for specialty
pharmaceuticals … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2014 Apr 10]. [5 p].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - Drugs that are
not approved by the FDA have been
removed. … Drugs that are
not approved by the FDA have been
removed. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Results 1. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Results 1. … Weiglein;
Takeda
Pharmaceuticals
North America,
Inc
Discussion 1.
-
effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
December 01, 2020 - Six classes of drugs and nasal saline are used to treat SAR. … Several drugs have more than one route of administration (e.g., intranasal and oral), as described below … These drugs are commonly administered prophylactically, before an allergic reaction is triggered, during … for clinical trials, data demonstrating efficacy and maternal and fetal safety are lacking for most drugs … Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
May 01, 2008 - Use of anti-dementia drugs was similar across settings,
with 24.7% of dementia cases in the community … larger than in the community,
but there is little difference in the proportions receiving anti-dementia drugs … In a previous study, the authors13 reviewed 81 recent randomized clinical trials of dementia
drugs … Our analysis of drugs typically used to treat behavioral manifestations of dementia found that
treatment … these utilization rates are not adjusted for potential
confounding factors, we cannot conclude the drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - longitudinal pro-
pensity score to compare outcomes between a new drug (exenatide)
and established drugs … We used our methods to estimate the effect
of the new versus established drugs on total health care charges … Additionally,
a separate, linkable file is available which includes pharmacy
claims for prescription drugs … May 2005 14,052 0.00 0.46 0.45
Emergency room visit June 2005 36 0.00 0.47 0.49
No. drugs June 2005 … This methodology has particular value for the study of
new drugs.
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-harms/methods
May 01, 2020 - for most regulatory approvals, and the source of most advertising and other claims made on behalf of drugs … For example, a systematic review of nonsteroidal anti-inflammatory drugs (NSAIDs) found cyclo-oxygenase … Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and … A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs … Causality assessment of adverse reactions to drugs-I.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - Dosing of nonsteroidal anti-inflammatory drugs (NSAIDS). … No not everyone who is on an opiod ends
up on street drugs. … This war on drugs came
into existence during the Nixon era. … We still have
more people overdosing on drugs and
alcohol than ever before. … It is illegal drugs
that are causing our problem and lack of
education of our citizens.
-
effectivehealthcare-admin.ahrq.gov/health-topics/liver-diseases
October 23, 2014 - Diseases caused by viruses, such as hepatitis A, hepatitis B , and hepatitis C
Diseases caused by drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
January 01, 2009 - migraine patients require multiple
doses and often do not relieve the migraine and that some other drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or bioequivalence study
data for drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Results
The table below lists the six topics for which (1) preliminary phase III data for drugs, at … of this therapy for both drugs. … Intarcia Therapeutics, Inc., Hayward, CA), is extended-release
exenatide for injection (Bydureon™, Amylin Pharmaceuticals … Get drugs straight to the eye.
[internet].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - Drugs Aging. 2013 Oct;30(10):793-
807. doi: 10.1007/s40266-013-0106-8. PMID:
23912674.
11. … Anti-hypertensive drugs deprescribing: an updated
systematic review of clinical trials. … Drugs Aging. 2019 Dec;36(12):1097-110. doi:
10.1007/s40266-019-00717-1. PMID: 31598908. … Withdrawal of antihypertensive drugs in older
people. … Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. PMID:
23912674.